Protocol for Northern Blot

Reagents and chemicals

• Use purified total RNA or poly(A)+ RNA from the selected biological model as the analyte; use agarose-formaldehyde or glyoxal/DMSO denaturing gels for mRNA and long RNA analysis, because RNA secondary structure must be disrupted for size-based migration^[2][3][7].

• Use urea-polyacrylamide gels for small RNA targets such as miRNA, siRNA, or piRNA, because short RNAs require higher-resolution denaturing electrophoresis than standard agarose gels^[8][9].

Antibodies, probes, dyes, or kits

• Use target-specific labeled DNA probes, RNA riboprobes, radiolabeled probes, or validated DIG-labeled probes for sequence-specific RNA detection^[2][10][11].

• Use total-RNA/rRNA staining to evaluate RNA integrity, loading, and transfer before target-signal interpretation^[4].

Cells, tissues, isolated organs, organoids, or animals

• Use cancer cells, primary neurons, mouse tumor tissue, intestinal organoids, inflammatory macrophages, or drug-treated cultures only as RNA sources; Northern blot is performed on extracted RNA rather than intact biological samples^[2][5].

Buffers and solutions

• Prepare RNase-free denaturing loading buffer, electrophoresis buffer, transfer buffer, prehybridization buffer, hybridization buffer, and wash buffers with stringency matched to probe length and target sequence^[2][3][7].

Equipment and instruments

• Use RNase-free electrophoresis equipment, gel casting apparatus, capillary or downward blotting setup, nylon membrane, UV crosslinker or EDC crosslinking setup for small RNAs, hybridization oven, phosphorimager, autoradiography system, or chemiluminescence imager^[2][8][9].

Controls

• Include RNA size markers, positive-control RNA known to express the target, negative-control RNA when available, untreated or vehicle-treated control for drug screening, and total RNA/rRNA loading control; use housekeeping transcripts only if stable in the specific model and treatment condition^[4][5][6].

Preparation Steps

• Extract RNA from cancer cells, neurons, tumors, organoids, macrophages, or treated cultures using an RNA-preserving method, quantify RNA, and confirm integrity before gel loading^[2][4][5].
• Design or obtain a probe complementary to the target RNA region; select radiolabeled probes for high sensitivity or DIG-labeled probes when a validated nonradioactive format is preferred^[2][10][11].
• Choose the gel system according to expected RNA size: denaturing agarose for mRNA/long RNA and denaturing urea-polyacrylamide for small RNA^[2][8][9].

Operation Steps

• Denature equal amounts of RNA in loading buffer and load samples with RNA size markers on the selected denaturing gel^[2][3].
• Electrophorese until the expected target-size range is resolved; report RNA input, gel type, denaturant, gel concentration, buffer, and running conditions because these vary across Northern blot formats^[2][3][7].
• Visualize total RNA or rRNA to confirm integrity and comparable loading before transfer when compatible with downstream hybridization^[4].
• Transfer RNA from gel to nylon membrane by capillary transfer or validated alkaline/downward transfer, then immobilize long RNA by UV crosslinking^[2][12].
• For small RNA targets, immobilize RNA using EDC-mediated crosslinking, which improves detection of miRNA, siRNA, and piRNA compared with standard UV crosslinking^[8][9].
• Prehybridize the membrane, hybridize with the labeled target-specific probe, wash under appropriate stringency, and detect the signal by phosphorimaging, autoradiography, or validated chemiluminescent detection^[2][3][10].
• Strip and re-probe the membrane only when the membrane fixation and detection method support sequential hybridization^[2][3].

Data Acquisition and Analysis

• Acquire nonsaturated images and quantify target bands by densitometry or phosphorimager signal; normalize target signal to total RNA/rRNA membrane signal or a validated reference transcript^[2][4].
• Interpret both band size and intensity: altered size may suggest alternative processing, degradation, or cross-hybridization, while altered intensity suggests relative abundance change only after RNA integrity, loading, and transfer are controlled^[2][3].
• For cancer, neuronal, tumor, organoid, macrophage, or drug-screening experiments, use independent biological RNA preparations and technical replicate blots or lanes when possible; absence of signal should be interpreted cautiously because RT-PCR can detect some low-abundance transcripts missed by Northern blot^[5][6].

Problem: No target band.

Possible Cause: low abundance RNA, degraded RNA, weak probe, or insufficient input.
Literature-supported Solution: confirm RNA integrity, use poly(A)+ RNA when appropriate, use high-specific-activity or validated DIG probes, and consider RT-PCR for low-abundance targets^[2][5][10].

Problem: Smearing.

Possible Cause: degraded RNA or incomplete denaturation.
Literature-supported Solution: use intact RNA and denaturing agarose-formaldehyde or glyoxal/DMSO electrophoresis for long RNA^[2][3][7].

Problem: Apparent expression change may be false.

Possible Cause: unequal RNA loading or transfer.
Literature-supported Solution: quantify total RNA or rRNA on the membrane and normalize target signal accordingly^[4].

Problem: Weak small-RNA signal.

Possible Cause: inefficient immobilization of short RNA.
Literature-supported Solution: use EDC-mediated crosslinking for miRNA, siRNA, piRNA, or similar short RNAs^[8][9].

Problem: High background or unexpected bands.

Possible Cause: nonspecific probe binding or inadequate wash stringency.
Literature-supported Solution: optimize probe design, hybridization, and wash stringency using standard Northern hybridization conditions^[2][3].